Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors-Reference-Cited by-同舟云学术

Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors

Published:2019-09-06 Issue:4 Volume:47 Page:870-880
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Ilhan Harun^ORCID,Lindner S.,Todica A.,Cyran C. C.,Tiling R.,Auernhammer C. J.,Spitzweg C.,Boeck S.,Unterrainer M.,Gildehaus F. J.,Böning G.,Jurkschat K.,Wängler C.,Wängler B.,Schirrmacher R.,Bartenstein P.

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-019-04501-6.pdf

Reference25 articles.

1. Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335–42. https://doi.org/10.1001/jamaoncol.2017.0589 .

2. Reubi JC, Waser B. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging. 2003;30:781–93. https://doi.org/10.1007/s00259-003-1184-3 .

3. Bozkurt MF, Virgolini I, Balogova S, Beheshti M, Rubello D, Decristoforo C, et al. Guideline for PET/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated somatostatin receptor targeting peptides and (18)F-DOPA. Eur J Nucl Med Mol Imaging. 2017;44:1588–601. https://doi.org/10.1007/s00259-017-3728-y .

4. Banerjee SR, Pomper MG. Clinical applications of Gallium-68. Appl Radiat Isot. 2013;76:2–13. https://doi.org/10.1016/j.apradiso.2013.01.039 .

5. Lottes G, Gorschluter P, Kuwert T, Adam D, Schober O. Costs of F-18-FDG PET: experience with a satellite concept. Nuklearmedizin. 1998;37:159–64 discussion 65.

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies;Current Problems in Cancer;2024-10

2. (SiFA)SeFe: A Hydrophilic Silicon-Based Fluoride Acceptor Enabling Versatile Peptidic Radiohybrid Tracers;Journal of Medicinal Chemistry;2024-08-08

3. Radiolabeled Somatostatin Analogs for Cancer Imaging;Seminars in Nuclear Medicine;2024-08

4. Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-20

5. Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NOTA-LM3 and head-to-head comparison with [68Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-15